Stop Drug related deaths increasing
Doctors
To change failed policies now
pediatricians, obstetricians, surgeons, addiction specialists and more
Latest Newsletter
COVID & DRUGS
Campaign
ACT NOW
Latest Newsletter
COVID & DRUGS
Campaign
Shadow
More >
In The News
Taking painkillers away from those in desperate need is a cruel health policy
Taking painkillers away from those in desperate need is a cruel health policy
Nice’s new guidelines prescribing exercise over drugs for chronic sufferers risk causing more distress
Government of Canada announces $20 million to help communities respond to increasing opioid-related overdoses (1)
Government of Canada announces $20 million to help communities respond to increasing opioid-related overdoses (1)
Projects will provide training and awareness on opioid overdose response to 2.4 million Canadians and enable the distribution of 58,000 naloxone kits
The Spike in Drug Overdose Deaths During the COVID-19 Pandemic and Policy Options to Move Forward
The Spike in Drug Overdose Deaths During the COVID-19 Pandemic and Policy Options to Move Forward
Since COVID-19 first started upending day-to-day life for Americans in March 2020, public health officials have been sounding the alarm about a potential surge in drug overdoses.
More >
Publications
Harm Reduction Responses in the Age of COVID-19 Documenting the experiences of people who use drugs in South Africa
Drugs in the Time of COVID: Interim Report Since the beginning of the first national coronavirus lockdown, Release has operated a public, online survey designed to monitor how people are buying their drugs. The purpose of this survey, which is open to anyone residing in the UK over the age of 18, is to determine the impact that the COVID-19 pandemic, and corresponding restrictions, have had on buying illegal substances.
What is drug policy evaluation and why is it important? Evaluation is essential for effective policymaking, helping ensure that policies and programmes have the desired effect, provide value for money and do not have negative unintended consequences. The importance of evaluation has been recognised in all EU drug strategies and in the strategies of many Member States.